» Articles » PMID: 18367021

Severe Paroxysmal Hypertension (pseudopheochromocytoma)

Overview
Date 2008 Mar 28
PMID 18367021
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Paroxysmal hypertension always engenders a search for a catecholamine-secreting pheochromocytoma. Yet 98% of people with paroxysmal hypertension do not have this tumor. The cause and management of paroxysmal hypertension remain a mystery, and the subject of remarkably few papers. This review presents an approach to understanding and successfully treating this disorder. Patients experience symptomatic blood pressure surges likely linked to sympathetic nervous system stimulation. A specific personality profile associated with this disorder suggests a psychological basis, attributable to repressed emotion related to prior emotional trauma or a repressive (nonemotional) coping style. Based on this understanding, three forms of intervention, alone or in combination, appear successful: antihypertensive therapy with agents directed at the sympathetically mediated blood pressure elevation (eg, combined alpha- and beta-blockade or central alpha-agonists such as clonidine); psychopharmacologic interventions including anxiolytic and/or antidepressant agents; and psychological intervention, particularly reassurance and increased psychological awareness. An appropriately selected intervention can reduce or eliminate attacks in most patients.

Citing Articles

Perioperative management of patients with glioblastoma copresenting with pheochromocytoma: illustrative case.

Guo E, Keough M, Henderson A, Hagen E, Levine M, Arnason T J Neurosurg Case Lessons. 2024; 8(21).

PMID: 39556820 PMC: 11579913. DOI: 10.3171/CASE24374.


Correction of carotid artery stenosis by stent placement ameliorated paroxysmal hypertension after radiation treatment of hypopharyngeal carcinoma: a case report.

Brook I, Cohen E, Stemer A J Med Case Rep. 2022; 16(1):70.

PMID: 35172903 PMC: 8851753. DOI: 10.1186/s13256-022-03293-y.


Paroxysmal Hypertensive Episodes Caused by Direct Massage of the Carotid Artery by a Doppler Ultrasound of the Neck in a Laryngectomee.

Brook I J Med Ultrasound. 2020; 28(2):114-116.

PMID: 32874871 PMC: 7446695. DOI: 10.4103/JMU.JMU_77_19.


Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge.

Dyer K, Vettese T J Gen Intern Med. 2019; 35(2):586-589.

PMID: 31705462 PMC: 7018868. DOI: 10.1007/s11606-019-05503-8.


Pseudopheochromocytoma.

Mamilla D, Gonzales M, Esler M, Pacak K Endocrinol Metab Clin North Am. 2019; 48(4):751-764.

PMID: 31655774 PMC: 6903402. DOI: 10.1016/j.ecl.2019.08.004.


References
1.
Pacak K, Linehan W, Eisenhofer G, Walther M, Goldstein D . Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001; 134(4):315-29. DOI: 10.7326/0003-4819-134-4-200102200-00016. View

2.
Mann S . Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens. 2003; 16(10):881-8. DOI: 10.1016/s0895-7061(03)00978-6. View

3.
Kuchel O, Buu N, Larochelle P, Hamet P, Genest Jr J . Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited. Arch Intern Med. 1986; 146(7):1315-20. View

4.
Stein P, Black H . A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine (Baltimore). 1991; 70(1):46-66. DOI: 10.1097/00005792-199101000-00004. View

5.
Streeten D, Anderson Jr G, Lebowitz M, SPELLER P . Primary hyperepinephrinemia in patients without pheochromocytoma. Arch Intern Med. 1990; 150(7):1528-33. View